Deals...IMO, I also believe it will be positive. However, are you saying that the PR associated with OX1 migrating to Phase II is completely in Shire's hands? Lets say it goes to Phase II, and there is no PR from Shire, but, it reflects on FDA clinical trials website, can Maza announce a PR via media?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.